Melax Tech Achieves SOC 2 Type 2 Compliance from the American Institute of Certified Public Accountants (AICPA)
Nov 17, 2022
The Independent audit demonstrates compliance and offers suitability of controls' design and operating effectiveness.
Houston, TX: Melax Tech, a world leader in biomedical Natural Language Processing (NLP) Technology, announced successfully completing its 2022 independent SOC 2 Type 2 compliance audit covering its clinical machine learning and natural language processing solutions and systems. This milestone is a significant move for Melax Tech and its commitment to the highest data security and compliance levels.
SOC 2 is a framework composed of five “trust principles” for assessing the risk and potential improvement opportunities associated with the information security of an organization. Achieving SOC compliance assures existing and future customers of our commitment to data privacy and the three foundations of security; confidentiality, integrity, and availability, says Andre Pontin, Chief Executive Officer at Melax Tech.
This news comes in the wake of data privacy and security roadmap initiatives for the company, including:
· Augmentation of existing data privacy policies and strengthening of associated controls.
· Phased implementation of a DevSecOps Pipeline - (Phase 1 complete)
· Harmonization of internal information security and cyber security training requirements to ensure that Melax Tech employees, consultants, and contractors are armed with associated best practices.
Achieving SOC compliance entailed resource commitments and unwavering support from the Melax Tech CEO, Andre Pontin. Achieving this milestone demonstrates the collective knowledge of the Melax Tech security team and provides assurance of our commitment to data privacy and an evolving security posture, says Cynthia Freeney, Project Manager and Security Officer at Melax Tech.
To learn more about Melax Tech’s commitment to data security and compliance, visit melaxtech.com/data-security.
About Melax Tech: Melax Tech empowers healthcare and life science organizations to use data science approaches such as AI / Natural Language Processing (NLP) technology to extract information from biomedical textual data to solve real-world problems.